Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-depolarizing muscle relaxants and intraocular pressure in glaucoma and non-glaucoma ophthalmic surgery patients
ChiCTR-IPD-17012514Phase 4Recruiting
- Sponsor
- Eye, Ear, Nose, and Throat Hospital
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rocuronium and cisatracurium in Glaucoma and ocular hypertension (10 arms), sponsored by Eye, Ear, Nose, and Throat Hospital. Primary endpoint: intraocular pressure. Started Sep 2017; status: recruiting.
02
Drugs
rocuroniumcisatracurium
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on ChiCTR-IPD-17012514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPD-17012514.